McKenna Mark C. 4
4 · Apogee Therapeutics, Inc. · Filed Jun 20, 2025
Insider Transaction Report
Form 4
McKenna Mark C.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+14,461→ 14,461 totalExercise: $41.66Exp: 2035-06-17→ Common Stock (14,461 underlying)
Footnotes (1)
- [F1]This option represents the right to purchase 14,461 shares of the Issuer's common stock and will vest on the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such vesting date.